Delivery Order SPE2DX22D0089-SPE2D825F3B07
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,640.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vehicle running through December 2026. The contract was competitively awarded...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $91,278.31 firm fixed price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract will be performed at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $181,081.98 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under which AmerisourceBergen will supply pharmaceutical products and medical supplies to support federal military and healthcare operations. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,708.79 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 23, 2025, with a completion date of September 24, 2025. This competitive award utilized firm fixed-price pricing with no set-aside designation. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $32,142.24 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The company, headquartered...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,740.44 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery order is structured as a child contract under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,413.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation and will be performed at the vendor's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,775.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively...
- SPE2DX22D0089Indefinite Delivery Contract
- SPE2DX22D0089-SPE2D825F3B07Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $7,931.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 22, 2025, with a completion date of September 23, 2025. This firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9M and extending through December 2026. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a major pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen fulfills delivery orders spanning various medical products including brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies. The company's extensive federal contracting history demonstrates its capability to execute small-value transactions through large-scale pharmaceutical support operations on a competitive basis. This particular delivery order represents routine procurement activity under the broader global pharmaceutical support vehicle, supporting defense healthcare requirements worldwide through the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 9/22/25 |